Led N-Power Medicine's Series B financing, bringing its total funding to $72M, to bolster access to community oncology clinical trials.
N-Power Medicine is building the first always-on clinical research system in community oncology to dramatically boost clinical trial participation and realize the promise of prospective external controls to accelerate and de-risk oncology R&D
N-Power Medicine is building the first always-on clinical research system in community oncology to dramatically boost clinical trial participation and realize the promise of prospective external controls to accelerate and de-risk oncology R&D.